Valuation: Philadelphia Pharmaceuticals Company

Market Cap 15M 21.16M 18.33M 17.33M 15.73M 29.49M 2.03B 29.66M 207M 79.94M 1.03B 79.47M 77.71M 3.28B P/E 2024
13.7x
P/E 2025 11.9x
Enterprise Value 14.93M 21.06M 18.25M 17.25M 15.66M 29.35M 2.02B 29.53M 206M 79.58M 1.02B 79.12M 77.36M 3.27B EV / Sales 2024
1.32x
EV / Sales 2025 1.3x
Free-Float
7.27%
Yield 2024
4.67%
Yield 2025 -
1 day+6.95%
1 week+5.26%
Current month+5.26%
1 month+1.01%
3 months+19.05%
6 months+25.79%
Current year+25.00%
1 week 2
Extreme 2
2
1 month 1.84
Extreme 1.84
2
Current year 1.5
Extreme 1.5
2.01
1 year 1.48
Extreme 1.48
2.01
3 years 1.36
Extreme 1.36
2.01
5 years 1.28
Extreme 1.28
2.01
10 years 1.28
Extreme 1.28
3.19
Manager TitleAgeSince
Chief Executive Officer 44 01/01/2013
Chief Tech/Sci/R&D Officer - -
Director of Finance/CFO 50 01/01/2002
Director TitleAgeSince
Chairman 58 -
Director/Board Member 61 01/09/2016
Director/Board Member 64 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
+6.95%+5.26%+30.72%+39.86% 21.16M
+1.01%-0.61%+15.09%+61.20% 45.9B
+3.03%-1.96%+38.13%+101.80% 38.7B
+0.77%-1.77%+7.06%+71.61% 11.43B
+0.52%-0.37%-12.89%+9.92% 11.38B
+0.96%+0.57%+19.32%+148.82% 9.09B
-0.47%+0.16%+27.34%+36.96% 7.3B
+1.61%-1.03%+16.03%+181.38% 6.98B
+1.70%+1.13%+38.60%-19.02% 7.13B
+0.61%-5.43%-43.52%+5.23% 4.89B
Average +1.67%-0.86%+13.59%+63.77% 14.28B
Weighted average by Cap. +1.48%-2.55%+18.57%+73.23%

Financials

2024 2025
Net sales 8.76M 12.36M 10.71M 10.12M 9.19M 17.22M 1.19B 17.33M 121M 46.7M 601M 46.43M 45.4M 1.92B 9.17M 12.93M 11.21M 10.59M 9.62M 18.02M 1.24B 18.13M 126M 48.86M 629M 48.58M 47.5M 2.01B
Net income 822K 1.16M 1M 949K 862K 1.61M 111M 1.62M 11.33M 4.38M 56.38M 4.35M 4.26M 180M 1.01M 1.42M 1.23M 1.16M 1.05M 1.98M 136M 1.99M 13.86M 5.36M 68.98M 5.33M 5.21M 220M
Net Debt 334K 471K 408K 385K 350K 656K 45.14M 660K 4.6M 1.78M 22.9M 1.77M 1.73M 72.98M -67.69K -95.47K -82.73K -78.19K -70.99K -133K -9.16M -134K -933K -361K -4.65M -359K -351K -14.81M
Logo Philadelphia Pharmaceuticals Company
Philadelphia Pharmaceuticals Industry Company PSC is a Jordan-based company that is engaged in the development, manufacture and marketing of human pharmaceutical products of different therapeutic categories. The Company, through its production facilities and laboratories located in Amman Industrial state, develops and produces a number of products that includes: Semisolid Dosage Forms, such as creams, ointments, lotions, gels and suppositories, as well as Liquid Dosage Forms, which include syrups, suspensions, solutions, nasal, drops, mouth washes and vaginal douches. Furthermore, the Company undertakes the distribution and marketing of a range of healthcare systems, miscellaneous and pharmaceuticals of different international brand names, including alimentary, gastrointestinal systems and respiratory systems. The Company markets its products to the local markets and exports to more than 10 countries in the Middle East and North Africa region.
Employees
129
Date Price Change Volume
14/09/26 JOD 2.000 +6.95% 10
  1. Stock Market
  2. Stocks
  3. PHIL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!